Skip to Main Content

Author Details

Mark Lee
Memorial Sloan Kettering Cancer Center (MSKCC)
2015
17
12
PMIDPaper TitleJournal TitlePublished Year
37561583Clinical-genomic determinants of immune checkpoint blockade response in head and neck squamous cell carcinoma.J Clin Invest2023
34725502Improved prediction of immune checkpoint blockade efficacy across multiple cancer types.Nat Biotechnol2022
35797031Association Between Toxic Effects and Survival in Patients With Cancer and Autoimmune Disease Treated With Checkpoint Inhibitor Immunotherapy.JAMA Oncol2022
35817971Functional landscapes of POLE and POLD1 mutations in checkpoint blockade-dependent antitumor immunity.Nat Genet2022
33398197The association between tumor mutational burden and prognosis is dependent on treatment context.Nat Genet2021
33599686Response Rates to Anti-PD-1 Immunotherapy in Microsatellite-Stable Solid Tumors With 10 or More Mutations per Megabase.JAMA Oncol2021
33526794Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors.Nat Commun2021
34381934<i>TERT</i> Promoter Mutations Are Enriched in Oral Cavity Cancers and Associated With Locoregional Recurrence.JCO Precis Oncol2021
347714773p Arm Loss and Survival in Head and Neck Cancer: An Analysis of TCGA Dataset.Cancers (Basel)2021
34039647High Response Rate and Durability Driven by HLA Genetic Diversity in Patients with Kidney Cancer Treated with Lenvatinib and Pembrolizumab.Mol Cancer Res2021
34080309Model-based assessments of CYP3A-mediated drug-drug interaction risk of milademetan.Clin Transl Sci2021
31361563Tumor mutational burden as a predictive biomarker for checkpoint inhibitor immunotherapy.Hum Vaccin Immunother2020
31768066High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants.Nat Med2019
28187279Next-Generation Sequencing of Circulating Tumor DNA for Early Cancer Detection.Cell2017
27863403Enumeration and targeted analysis of KRAS, BRAF and PIK3CA mutations in CTCs captured by a label-free platform: Comparison to ctDNA and tissue in metastatic colorectal cancer.Oncotarget2016
25575824Mutation profiling of tumor DNA from plasma and tumor tissue of colorectal cancer patients with a novel, high-sensitivity multiplexed mutation detection platform.Oncotarget2015
26527805Circulating Tumor Cells and Circulating Tumor DNA: Challenges and Opportunities on the Path to Clinical Utility.Clin Cancer Res2015
  • 1 - 17 of 17

Recommended Authors

Walid K Chatila
Memorial Sloan Kettering Cancer Center
Career Start Year 2017
Number of shared co-authors 9
Wei Yuan
The Institute for Cancer Research
Career Start Year 2015
Number of shared co-authors 4
Zachary L Skidmore
Washington University in St. Louis School of Medicine
Career Start Year 2015
Number of shared co-authors 0
Adam A Kraya
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Career Start Year 2015
Number of shared co-authors 0
Damian T Rieke
German Cancer Consortium and German Cancer Research Center
Career Start Year 2015
Number of shared co-authors 0
Katie M Campbell
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 2014
Number of shared co-authors 0
Chen Wang
College of Life Sciences, Sichuan University
Career Start Year 2013
Number of shared co-authors 1
Jianjun Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year 2012
Number of shared co-authors 5
Arshi Arora
Memorial Sloan Kettering Cancer Center
Career Start Year 2011
Number of shared co-authors 3
Stephanie S Yee
University of Pennsylvania
Career Start Year 2010
Number of shared co-authors 1
Melissa C Larson
Mayo Clinic
Career Start Year 2010
Number of shared co-authors 1
Davide Bedognetti
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Career Start Year 2010
Number of shared co-authors 0
Eliezer M Van Allen
Dana-Farber Cancer Institute
Career Start Year 2009
Number of shared co-authors 6
Benjamin G Vincent
UNC School of Medicine, The University of North Carolina at Chapel Hill
Career Start Year 2008
Number of shared co-authors 0
Oscar Krijgsman
The Netherlands Cancer Institute
Career Start Year 2008
Number of shared co-authors 0
Linghua Wang
The University of Texas M. D. Anderson
Career Start Year 2006
Number of shared co-authors 0
Samuel S Freeman
St Vincent's Hospital Melbourne
Career Start Year 2006
Number of shared co-authors 0
Rodrigo Dienstmann
Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus
Career Start Year 2006
Number of shared co-authors 1
Albrecht Stenzinger
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 3
Peter Horak
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Career Start Year 2003
Number of shared co-authors 1
Lixia Diao
The University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 3
Jianhua Zhang
University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 1
Trevor J Pugh
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2003
Number of shared co-authors 1
Simon Kreutzfeldt
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Career Start Year 2002
Number of shared co-authors 1
Philippe L Bedard
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2002
Number of shared co-authors 4
Debyani Chakravarty
Memorial Sloan Kettering Cancer Center
Career Start Year 2002
Number of shared co-authors 15
Martijn P Lolkema
Erasmus MC Cancer Institute
Career Start Year 1999
Number of shared co-authors 3
Charles Swanton
Francis Crick Institute
Career Start Year 1997
Number of shared co-authors 7
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1996
Number of shared co-authors 0
Hira Rizvi
Druckenmiler Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center
Career Start Year 1978
Number of shared co-authors 4

Collaborators

Luc G T Morris
Memorial Sloan Kettering Cancer Center
Co-authored papers 11
Timothy A Chan
Cleveland Clinic.
Co-authored papers 8
Nadeem Riaz
Memorial Sloan Kettering Cancer Center
Co-authored papers 6
Michael F Berger
Co-authored papers 4
Marc Ladanyi
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
Daniel W Kelly
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Vladimir Makarov
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Co-authored papers 3
Mithat Gonen
Co-authored papers 3
Abraham Ari Hakimi
Co-authored papers 3
Richard J Wong
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Brendan C Visser
Co-authored papers 2
Fengshen Kuo
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Xin Pei
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Nancy Y Lee
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Gregory J Riely
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Sante Gnerre
Co-authored papers 1
Laura Jarycki
University of Western Ontario
Co-authored papers 1
Mohammed I Khan
Stanford University
Co-authored papers 1
Niels Weinhold
Co-authored papers 1
Alexander W Blocker
Co-authored papers 1
Krishna Juluru
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
John W Barrett
University of Western Ontario
Co-authored papers 1
Halema Khan
University of Western Ontario
Co-authored papers 1
Jay O Boyle
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Kevin Fung
Schulich School of Medicine & Dentistry, Western University, Victoria Hospital
Co-authored papers 1
Krupal B Patel
Moffitt Cancer Center
Co-authored papers 1
Anthony C Nichols
University of Western Ontario
Co-authored papers 1
Charles M Rudin
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Paul C Boutros
University of California los angeles
Co-authored papers 1
Raymond S Lim
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Release 1.2